|

PT0511 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • PAQ Therapeutics, Inc.1

Indications

  • Pancreatic Cancer1
  • Solid Tumor1
  • Colorectal Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Boston, Massachusetts1 trial

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

Dana-Farber/Massachusetts General Hospital, Inc

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.